These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


457 related items for PubMed ID: 31865663

  • 41. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
    Yoo MH, Lim WS, Park JH, Kwon JK, Lee TH, An YH, Kim YJ, Kim JY, Lim HW, Park HJ.
    Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
    [Abstract] [Full Text] [Related]

  • 42. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
    Suzuki H, Wakasugi T, Kitamura T, Koizumi H, Do BH, Ohbuchi T.
    Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
    [Abstract] [Full Text] [Related]

  • 43. Comparison of intratympanic dexamethasone therapy and hyperbaric oxygen therapy for the salvage treatment of refractory high-frequency sudden sensorineural hearing loss.
    Sun H, Qiu X, Hu J, Ma Z.
    Am J Otolaryngol; 2018 Apr; 39(5):531-535. PubMed ID: 29891394
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial.
    Chang WT, Zee B, Lee HSH, Tong MCF.
    Am J Otolaryngol; 2020 Apr; 41(4):102515. PubMed ID: 32487334
    [Abstract] [Full Text] [Related]

  • 47. Hyperbaric Oxygen Therapy Versus Intratympanic Steroid for Salvage Treatment of Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.
    Lei X, Feng Y, Xia L, Sun C.
    Otol Neurotol; 2021 Sep 01; 42(8):e980-e986. PubMed ID: 34172651
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Comparison of two different intratympanic corticosteroid injection protocols as salvage treatments for idiopathic sudden sensorineural hearing loss.
    Andrianakis A, Moser U, Kiss P, Holzmeister C, Andrianakis D, Tomazic PV, Wolf A, Graupp M.
    Eur Arch Otorhinolaryngol; 2022 Feb 01; 279(2):609-618. PubMed ID: 33591388
    [Abstract] [Full Text] [Related]

  • 50. Intratympanic Methylprednisolone versus Dexamethasone for the Primary Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
    Tarkan Ö, Dağkıran M, Sürmelioğlu Ö, Özdemir S, Tuncer Ü, Doğrusöz M, Çetik F, Kıroğlu M.
    J Int Adv Otol; 2018 Dec 01; 14(3):451-455. PubMed ID: 30431012
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Efficacy of intratympanic steroid therapy for idiopathic sudden sensorineural hearing loss: comparison with systemic steroid therapy and combined therapy.
    Bae SC, Noh HI, Jun BC, Jeon EJ, Seo JH, Park SY, Kim JK, Lee DH, Oh JH, Park SN, Yeo SW.
    Acta Otolaryngol; 2013 May 01; 133(5):428-33. PubMed ID: 23356871
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Efficacy of low-dose intratympanic dexamethasone for sudden hearing loss.
    Günel C, Başal Y, Toka A, Eryılmaz A, Kurt Ömürlü I.
    Auris Nasus Larynx; 2015 Aug 01; 42(4):284-7. PubMed ID: 25725564
    [Abstract] [Full Text] [Related]

  • 55. Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss.
    Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T.
    Eur Arch Otorhinolaryngol; 2007 Aug 01; 264(8):861-6. PubMed ID: 17340130
    [Abstract] [Full Text] [Related]

  • 56. Salvage intratympanic steroid therapy for sudden sensorineural hearing loss: our real-life experience in 32 patients.
    Ringrose T, Biggs TC, Jones L, Yunus A, Onderková A, Amir-Ghasemi A, Osei-Lah V, Hilton J, Buckland J.
    J Laryngol Otol; 2022 Sep 01; 136(9):827-830. PubMed ID: 35018883
    [Abstract] [Full Text] [Related]

  • 57. Nationwide Survey of Intratympanic Steroids for the Management of Sudden Sensorineural Hearing Loss.
    Levy E, Sela E, Letichevsky V, Ronen O.
    Isr Med Assoc J; 2019 Feb 01; 21(2):105-109. PubMed ID: 30772961
    [Abstract] [Full Text] [Related]

  • 58. High Dose of Intratympanic Steroids for Sudden Sensorineural Hearing Loss Salvage.
    Taha A, Shlamkovitch N, Abu-Eta R, Yeheskeli E, Muallem-Kalmovich L, Gavriel H, Pitaro J.
    Otol Neurotol; 2019 Oct 01; 40(9):1134-1138. PubMed ID: 31498293
    [Abstract] [Full Text] [Related]

  • 59. Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss.
    Raymundo IT, Bahmad F, Barros Filho J, Pinheiro TG, Maia NA, Oliveira CA.
    Braz J Otorhinolaryngol; 2010 Oct 01; 76(4):499-509. PubMed ID: 20835538
    [Abstract] [Full Text] [Related]

  • 60. Comparison of steroid administration methods in patients with idiopathic sudden sensorineural hearing loss: a retrospective observational study.
    Kim SH, Jung SY, Kim MG, Byun JY, Park MS, Yeo SG.
    Clin Otolaryngol; 2015 Jun 01; 40(3):183-90. PubMed ID: 25346100
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.